Disclosures for "Impact of Lipoprotein(a) on Recurrent Stroke Risk: A Stratified Analysis by Stroke Etiology."
-
Dr. Zhang has nothing to disclose.
-
Dr. Ali has nothing to disclose.
-
Dr. Cornier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novo nordisk. Dr. Cornier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Cornier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biophytis. Dr. Cornier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zyversa. The institution of Dr. Cornier has received research support from Novartis. The institution of Dr. Cornier has received research support from Amgen. The institution of Dr. Cornier has received research support from Kaneka. The institution of Dr. Cornier has received research support from Ionis.
-
Dr. Waring has nothing to disclose.
-
Dr. Mohamed has nothing to disclose.